EC/GEJC: Adjuvante Immuntherapie erg änzt kurativen Behandlungsansatz
Oncol Res Treat 2021;44:642 –644 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - November 1, 2021 Category: Cancer & Oncology Source Type: research
Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA
Background
In metastatic breast cancer, blood-based diagnostics have become a major focus of oncological research in the last two decades. Detection of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) has the potential to improve prognosis assessment and complement standard therapy monitoring tools.
Summary
To date, several large analyses have confirmed high CTC counts as an independent prognostic factor. Persistently high CTC numbers during systemic treatment are associated with early progression but it remains to be clarified which therapeutic options should be offered to such patients since the SWOG 0...
Source: Oncology Research and Treatment - October 29, 2021 Category: Cancer & Oncology Source Type: research
Evidence Mapping of Proton Therapy, Heavy Ion Therapy, and Helical Tomotherapy for Gastric Cancer
Conclusions: Existing studies presented good clinic treatment effect about PT and TOMO for GC, and furthermore clinical studies are needed.Oncol Res Treat (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 25, 2021 Category: Cancer & Oncology Source Type: research
Routine Cancer Treatment Regimens and Its Impact on Fine Motor Dexterity in Breast Cancer
Conclusion: Our study showed that the extent of change in fine motor dexterity depends on the treatment regimen. The detection of unmet care needs could help to personalize and optimize clinical and survivorship care. Based on our findings, multidisciplinary support initiated early in breast cancer therapy is required.Oncol Res Treat (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 13, 2021 Category: Cancer & Oncology Source Type: research
Preoperative Conization May Have a Positive Impact on Survival in Early-Stage Cervical Cancer: A Propensity-Matched Study
Conclusion: Preoperative conization in conjunction with MIS seemed to be a safe and feasible approach, with results that may have implications for the reduction of recurrence. Histologic cell type also impacted survival. Therefore, more future prospective studies are warranted.Oncol Res Treat (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 5, 2021 Category: Cancer & Oncology Source Type: research
Society Bulletins
Oncol Res Treat 2021;44:579 –582 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 1, 2021 Category: Cancer & Oncology Source Type: research
PharmaNews
Oncol Res Treat 2021;44:578 –578 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 1, 2021 Category: Cancer & Oncology Source Type: research
PharmaNews
Oncol Res Treat 2021;44:577 –577 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 1, 2021 Category: Cancer & Oncology Source Type: research
KRAS – ein neuer prädiktiver Biomarker am Horizont
Oncol Res Treat 2021;44:574 –576 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 1, 2021 Category: Cancer & Oncology Source Type: research
Aktuelles Interview: Therapieerfahrungen mit Glasdegib bei AML
Oncol Res Treat 2021;44:573 –573 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 1, 2021 Category: Cancer & Oncology Source Type: research
Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma
Conclusion: Our results indicate that induction chemotherapy plus concurrent chemoradiotherapy under intensity-modulated radiotherapy which is the standard therapeutic method for locally advanced NPC provides beneficial therapeutic effects, and it is worthy of further study.Oncol Res Treat (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - October 1, 2021 Category: Cancer & Oncology Source Type: research
Vorspann
Oncol Res Treat 2021;44:I –III (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - September 28, 2021 Category: Cancer & Oncology Source Type: research
Gemeinsame Jahrestagung der Deutschen, O ̈sterreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (Hybrid-Kongress), 01.-04. Oktober 2021: Abstracts
Oncol Res Treat 2021;44:1 –335 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - September 28, 2021 Category: Cancer & Oncology Source Type: research
Clinicopathological and Prognostic Features of 67 Cases with Pulmonary Sarcomatoid Carcinoma: An 18-Year Single-Centre Experience
Conclusion: PSC is an extremely rare and aggressive variant of NSCLC. Positive epithelial markers may have favourable prognostic significance in PSC. Resection of the tumour with a negative surgical margin is crucial for better survival. The prognosis of the disease is very poor in the metastatic stage.Oncol Res Treat (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - September 23, 2021 Category: Cancer & Oncology Source Type: research
Value of HSP90 α in Lung Cancer Diagnosis and Recurrence Prediction: A Cohort Study
Conclusion: Serum level of plasma HSP90 α could be a reliable biomarker in diagnosing lung cancer and its subtypes and might be a valid biomarker for predicting lung cancer relapse in patients treated with chemoradiotherapy and surgery.Oncol Res Treat (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - September 21, 2021 Category: Cancer & Oncology Source Type: research
